Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Nova MD

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Nova MD head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 244 · Grade C

Nova MD

Visit Nova MD Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 66 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Nova MD a bad call — it's best for readers who want to compare monthly and quarterly care while checking the selected pharmacy, formulation and state restrictions. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
58
Supply Reliability
95
69
Transparency
90
72
Access Breadth
93
50
Clinical Oversight
92
83
Track Record
88
68
CoreAge RxBrief Score 94 · 66Nova MD

Price, coverage & the tracker

CoreAge RxNova MD
Brief Score94/100 (A)66/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$175/month

Compounded semaglutide + B12; care, medication, supplies and shipping advertised as included.

Quarterly alternative: $387 every 3 months ($129/month equivalent); verify prescribed supply.

Full price details

$175/month for compounded semaglutide + B12; quarterly plan $387 every 3 months ($129/month equivalent); consultation, care, supplies and shipping advertised as included

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$199/month

Compounded injection; consultation, medication and shipping included.

Drug Crafters: $387 quarterly ($129/month equivalent), with state exclusions. Southend/Vials RX: $447 quarterly; formulation and pharmacy vary.

Full price details

$199/month for compounded tirzepatide; Drug Crafters quarterly $387 ($129/month equivalent), with state exclusions; Southend/Vials RX quarterly $447; formulation and pharmacy vary

CoverageUS only; restrictions by state, confirmed at intakeTreatment and pharmacy eligibility vary by state; Drug Crafters quarterly tirzepatide has a published exclusion list and a temporary Arkansas restriction
Brand-name accessNot confirmedThe named GLP-1 programs are compounded; current brand-name fulfillment was not established.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Nova MD: Monthly plans are $175/$199. The $129 equivalent requires a $387 quarterly payment; tirzepatide eligibility depends on pharmacy and state.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.